Pacira BioSciences' Cash & Current Investments fell 4571.87% to $246.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.3 million, marking a year-over-year decrease of 4571.87%. This contributed to the annual value of $484.6 million for FY2024, which is 7395.84% up from last year.
Latest data reveals that Pacira BioSciences reported Cash & Current Investments of $246.3 million as of Q3 2025, which was down 4571.87% from $445.9 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Cash & Current Investments peaked at $693.9 million during Q3 2021, and registered a low of $174.0 million during Q1 2023.
In the last 5 years, Pacira BioSciences' Cash & Current Investments had a median value of $404.2 million in 2024 and averaged $407.1 million.
In the last 5 years, Pacira BioSciences' Cash & Current Investments soared by 9786.13% in 2021 and then tumbled by 6152.12% in 2023.
Pacira BioSciences' Cash & Current Investments (Quarter) stood at $656.4 million in 2021, then crashed by 56.03% to $288.7 million in 2022, then fell by 3.49% to $278.6 million in 2023, then skyrocketed by 73.96% to $484.6 million in 2024, then tumbled by 49.17% to $246.3 million in 2025.
Its last three reported values are $246.3 million in Q3 2025, $445.9 million for Q2 2025, and $493.6 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value